These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 31129153)

  • 1. Sex differences in Alzheimer's disease: Understanding the molecular impact.
    Toro CA; Zhang L; Cao J; Cai D
    Brain Res; 2019 Sep; 1719():194-207. PubMed ID: 31129153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the impact of sex and gender in Alzheimer's disease: A call to action.
    Nebel RA; Aggarwal NT; Barnes LL; Gallagher A; Goldstein JM; Kantarci K; Mallampalli MP; Mormino EC; Scott L; Yu WH; Maki PM; Mielke MM
    Alzheimers Dement; 2018 Sep; 14(9):1171-1183. PubMed ID: 29907423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision medicine and drug development in Alzheimer's disease: the importance of sexual dimorphism and patient stratification.
    Hampel H; Vergallo A; Giorgi FS; Kim SH; Depypere H; Graziani M; Saidi A; Nisticò R; Lista S;
    Front Neuroendocrinol; 2018 Jul; 50():31-51. PubMed ID: 29902481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research.
    Dennison JL; Ricciardi NR; Lohse I; Volmar CH; Wahlestedt C
    J Alzheimers Dis; 2021; 80(1):41-52. PubMed ID: 33459720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2021 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2021 Mar; 17(3):327-406. PubMed ID: 33756057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of oxidative stress in the progression of Alzheimer's disease.
    Sultana R; Butterfield DA
    J Alzheimers Dis; 2010; 19(1):341-53. PubMed ID: 20061649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative.
    Snyder HM; Asthana S; Bain L; Brinton R; Craft S; Dubal DB; Espeland MA; Gatz M; Mielke MM; Raber J; Rapp PR; Yaffe K; Carrillo MC
    Alzheimers Dement; 2016 Nov; 12(11):1186-1196. PubMed ID: 27692800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurovascular Alterations in Alzheimer's Disease: Transporter Expression Profiles and CNS Drug Access.
    McInerney MP; Short JL; Nicolazzo JA
    AAPS J; 2017 Jul; 19(4):940-956. PubMed ID: 28462473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.
    Chen Y; Wang J; Cui C; Su Y; Jing D; Wu L; Liang P; Liang Z
    Aging (Albany NY); 2021 Feb; 13(5):7228-7246. PubMed ID: 33640881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.
    Kelly SC; He B; Perez SE; Ginsberg SD; Mufson EJ; Counts SE
    Acta Neuropathol Commun; 2017 Jan; 5(1):8. PubMed ID: 28109312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study.
    Yuan J; Maserejian N; Liu Y; Devine S; Gillis C; Massaro J; Au R
    J Alzheimers Dis; 2021; 79(2):807-817. PubMed ID: 33361590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex and gender differences in Alzheimer's disease: recommendations for future research.
    Carter CL; Resnick EM; Mallampalli M; Kalbarczyk A
    J Womens Health (Larchmt); 2012 Oct; 21(10):1018-23. PubMed ID: 22917473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
    Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
    PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of sex hormones in the development and progression of Alzheimer's disease.
    Radaghdam S; Karamad V; Nourazarian A; Shademan B; Khaki-Khatibi F; Nikanfar M
    Neurosci Lett; 2021 Nov; 764():136221. PubMed ID: 34500000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex Differences in Alzheimer's Disease: Insights From the Multiomics Landscape.
    Guo L; Zhong MB; Zhang L; Zhang B; Cai D
    Biol Psychiatry; 2022 Jan; 91(1):61-71. PubMed ID: 33896621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
    Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
    Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex and the development of Alzheimer's disease.
    Pike CJ
    J Neurosci Res; 2017 Jan; 95(1-2):671-680. PubMed ID: 27870425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome.
    Guo LH; Alexopoulos P; Eisele T; Wagenpfeil S; Kurz A; Perneczky R
    Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):325-33. PubMed ID: 22932720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.